ClearPoint Neuro (CLPT) Equity Average (2012 - 2026)

ClearPoint Neuro has disclosed Equity Average across 15 years of filings, most recently posting $23.4 million for Q1 2026.

• Equity Average for Q1 2026 came in at $23.4 million, up 3.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.4 million (up 3.27% YoY), and the FY2025 annual result was $26.7 million, up 14.71% from the prior year.
• Equity Average came in at $23.4 million for Q1 2026 at ClearPoint Neuro, up from $21.9 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $47.3 million in Q1 2022 to a low of $17.8 million in Q3 2025.
• The 5-year median for Equity Average is $27.9 million (2024), against an average of $29.9 million.
• Across the five-year window, Equity Average jumped 103.88% in 2022 and plunged 41.74% in 2025, its largest moves.
• ClearPoint Neuro's Equity Average stood at $38.4 million in 2022, then plunged by 41.03% to $22.6 million in 2023, then gained by 20.15% to $27.2 million in 2024, then dropped by 19.3% to $21.9 million in 2025, then gained by 6.76% to $23.4 million in 2026.
• The last three Equity Average figures came in at $23.4 million (Q1 2026), $21.9 million (Q4 2025), and $17.8 million (Q3 2025), per Business Quant data.